Smoking increases risk of second primary lung cancer (SPLC)
the ONA take:
According to a new study published in the journal Cancer, researchers have found that increased tobacco exposure is linked with a higher risk of developing second primary lung cancers (SPLCs) and current smokers have an elevated risk of mortality compared with former and never-smokers.
For the study, researchers identified 1,484 patients who underwent surgery for non-small cell lung cancer (NSCLC) bettween 1995 and 2008. The researchers then analyzed the rates of SPLC based on smoking status and history and examined overall survival, local control, distant metastases, and postoperative mortality.
Of the 1,484 patients identified, 98 were never-smokers. The researchers found that the incidence of SPLC at 3, 5, and 8 years was 5%, 8%, and 16%, respectively. Of the never-smokers, only 1 developed an SPLC. Analyses showed that smoking history was the only independent risk factor for developing SPLC (HR, 1.08; 95% CI: 1.02-1.16, P = 0.031), which results in an 8% increased risk for developing the disease per 10 pack-year history.
Researchers found similar rates of local control and distant metastases among all smoking smoking statuses. Never-smokers had a decreased postoperative mortality compared with ever-smokers.
Increased tobacco exposure is linked with a higher risk of developing second primary lung cancers.
The objective of the current study was to determine the effect of smoking on the development of second primary lung cancers (SPLCs) and other clinical outcomes after surgery for non–small cell lung cancer (NSCLC). SPLCs are rare in never–smokers.
Increasing tobacco exposure is associated with a higher risk of SPLC in patients with a history of smoking. Current smokers have an increased risk of mortality whereas former and never–smokers have comparable survival.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|